Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial

被引：0
|
作者：
Abbas Taher
Marjan Lashkari
Fariba Keramat
Seyyed Hamid Hashemi
Ladan Sedighi
Jalal Poorolajal
Maryam Mehrpooya
机构：
[1] Hamadan University of Medical Sciences,Department of Anesthesiology and Critical Care, School of Medicine
[2] Hamadan University of Medical Sciences,Department Infectious Disease, School of Medicine
[3] Shahid Beheshti university of Medical Sciences,Department of medical and surgical nursing, school of nursing and midwifery
[4] Hamadan University of Medical Sciences,Department of Epidemiology, School of Public Health
[5] Hamadan University of Medical Sciences,Department of Clinical Pharmacy, School of Pharmacy, Medicinal Plants and Natural Products Research Center
来源：
Wiener Medizinische Wochenschrift | 2023年 / 173卷
关键词：
Severe COVID-19 pneumonia; SARS-CoV-19 infection; Corticosteroids; Cytokine storm; Mechanical ventilation; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：140 / 151
页数：11
相关论文
共 50 条
  • [1] Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial
    Taher, Abbas
    Lashkari, Marjan
    Keramat, Fariba
    Hashemi, Seyyed Hamid
    Sedighi, Ladan
    Poorolajal, Jalal
    Mehrpooya, Maryam
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2023, 173 (5-6) : 140 - 151
  • [2] Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
    Toroghi, Negar
    Abbasian, Ladan
    Nourian, Anahid
    Davoudi-Monfared, Effat
    Khalili, Hossein
    Hasannezhad, Malihe
    Ghiasvand, Fereshteh
    Jafari, Sirous
    Emadi-Kouchak, Hamid
    Yekaninejad, Mir Saeed
    [J]. PHARMACOLOGICAL REPORTS, 2022, 74 (01) : 229 - 240
  • [3] Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
    Negar Toroghi
    Ladan Abbasian
    Anahid Nourian
    Effat Davoudi-Monfared
    Hossein Khalili
    Malihe Hasannezhad
    Fereshteh Ghiasvand
    Sirous Jafari
    Hamid Emadi-Kouchak
    Mir Saeed Yekaninejad
    [J]. Pharmacological Reports, 2022, 74 : 229 - 240
  • [4] High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial
    Maskin, Luis Patricio
    Bonelli, Ignacio
    Leonardo Olarte, Gabriel
    Palizas, Fernando
    Velo, Agostina E.
    Fernanda Lurbet, Maria
    Lovazzano, Pablo
    Kotsias, Sophia
    Attie, Shiry
    Lopez Saubidet, Ignacio
    Baredes, Natalio D.
    Setten, Mariano
    Oscar Rodriguez, Pablo
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 2022, 37 (04) : 491 - 499
  • [5] A randomized clinical trial study on the efficacy and safety of adalimumab and methylprednisolone pulse therapy in the treatment of COVID-19 patients with acute respiratory distress syndrome
    Yazdani, Omid
    Farahani, Ramin Hamidi
    Mosaed, Reza
    Asl, Amir Nezami
    Hazrati, Ebrahim
    [J]. IMMUNOPATHOLOGIA PERSA, 2023, 9 (02):
  • [6] Enhancing the Efficacy of Mesenchymal Stromal Cells in COVID-19-related Acute Respiratory Distress Syndrome
    Zhang, Haibo
    Slutsky, Arthur S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (03) : 222 - 224
  • [7] Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial
    Jesús Villar
    José M. Añón
    Carlos Ferrando
    Gerardo Aguilar
    Tomás Muñoz
    José Ferreres
    Alfonso Ambrós
    César Aldecoa
    Fernando Suárez-Sipmann
    Kevin E. Thorpe
    Peter Jüni
    Arthur S. Slutsky
    [J]. Trials, 21
  • [8] Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial
    Villar, Jesus
    Anon, Jose M.
    Ferrando, Carlos
    Aguilar, Gerardo
    Munoz, Tomas
    Ferreres, Jose
    Ambros, Alfonso
    Aldecoa, Cesar
    Suarez-Sipmann, Fernando
    Thorpe, Kevin E.
    Juni, Peter
    Slutsky, Arthur S.
    [J]. TRIALS, 2020, 21 (01)
  • [9] Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome
    Abdelkader, Ahmed A.
    Alsfouk, Bshra A.
    Saleh, Asmaa
    Abdelrahim, Mohamed E. A.
    Saeed, Haitham
    [J]. PHARMACEUTICS, 2024, 16 (07)
  • [10] A Retrospective Comparison of Clinical and Laboratory Aspects of Patients With COVID-19-Related Acute Respiratory Distress Syndrome (ARDS) and Non-COVID-19-Related ARDS
    Yildiz, Nazan
    Kaya, Ebru
    Sahin, Ayca Sultan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
12345